History of the development of corticosteroid therapy

Clinical and Experimental Rheumatology

Volumn 29, Issue 5 SUPPL. 68, 2011, Pages

  Benedek, T G ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Corticosteroids; Cortisone; Non steroidal anti inflammatory drugs; Rheumatoid arthritis

Indexed keywords

ACETYLSALICYLIC ACID; AZATHIOPRINE; CORTICOSTEROID; CORTICOTROPIN; CORTISONE; CORTISONE ACETATE; CYCLOPHOSPHAMIDE; DEHYDROCORTICOSTERONE; DEOXYCORTICOSTERONE ACETATE; DEXAMETHASONE; FLUDROCORTISONE; HYDROCORTISONE; INDOMETACIN; METHOTREXATE; METHYLPREDNISOLONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; PREDNISOLONE; PREDNISONE; TRIAMCINOLONE;

ACNE; ADRENAL CORTEX; APPETITE DISORDER; ARTICLE; BONE MARROW TOXICITY; BONE NECROSIS; CARDIOVASCULAR DISEASE; CATARACT; DEPRESSION; DRUG COST; DRUG ISOLATION; DRUG SYNTHESIS; EDEMA; ELECTROLYTE DISTURBANCE; EUPHORIA; GASTROINTESTINAL SYMPTOM; HIRSUTISM; HOSTILITY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INFECTION; INFLAMMATION; INSOMNIA; MEDICAL HISTORY; MENSTRUAL IRREGULARITY; MENTAL DISEASE; METABOLIC DISORDER; MUSCLE WEAKNESS; MUSCULOSKELETAL DISEASE; OSTEOARTHRITIS; OSTEOPOROSIS; PEPTIC ULCER; PRIORITY JOURNAL; PSEUDORHEUMATISM; PURPURA; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SHOCK; SIDE EFFECT; SKIN DISEASE; SODIUM RETENTION; TELANGIECTASIA;

ADDISON DISEASE; ADRENAL CORTEX HORMONES; ANIMALS; HISTORY, 20TH CENTURY; HUMANS; RHEUMATIC DISEASES;

EID: 81155145991     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (84)

1. th ed. New York, Appleton & Co., 1920, p. 859.
2. ROWNTREE LG, SWINGLE W, PFIFFNER JJ et al.: Treatment of Addison's disease with the cortical hormone of the suprarenal gland: summary of immediate results in twenty cases treated with the preparation made by Swingle and Pfiffner. JAMA, 1931; 97: 1446-53.
3. CARTLAND GF, KUIZENGA MH: The preparation of extracts containing the adrenal cortex hormone. J Biol Chem 1936; 116: 57-64.
4. MARTIN SC: Edward Calvin Kendall, 1950. In: FOX DM, MELDRUM M, REZAK I (Eds): Nobel Laureates in Medicine or Physiology. New York, Garland Publishing, 1990, pp. 303-7.
5. BENEDEK TG: Tadeus Reichstein, 1950. Op. cit. 4. 457-62.
6. MASON HL, MYERS CS, KENDALL EC: The chemistry of cystalline substances isolated from the suprarenal gland. J Biol Chem 1936; 114:613-31.
7. MASON HL, MYERS CS, KENDALL EC: Chemical studies of the suprarenal cortex. II. Identification of a substance which possesses the qualitative action of cortin; its conversion into a diketone closely related to androstenedione. J Biol Chem 1936; 116: 267-76.
8. MASON HL, HOEHN WM, KENDALL EC: Chemical studies of the suprarenal cortex. IV. Structures of compounds C, D, E, F, and G. J Biol Chem 1938; 124: 459-74.
9. WINTERSTEINER OP, PFIFFNER JJ: Chemical studies of the adrenal cortex. II. Isolation of several physiologically inactive crystalline compounds from active extracts. J Biol Chem 1935; 111:599-612.
10. MASON HL: Chemistry of the adrenal cortical hormone. Endocrinology, 1939; 25: 405-12.
11. KENDALL EC: Hormones of the adrenal cortex. Endocrinology 1942; 30: 853-60.
12. KENDALL EC: The adrenal cortex. Arch Pathol 1941; 32: 474-501.
13. KENDALL EC: Glandular physiology and therapy. The function of the adrenal gland. JAMA 1941; 116:2394-98.
14. PEMBERTON R, SCULL CS: The role of central factors in the pathogenesis of rheumatic disorders. Ann Intern Med 1943; 19: 482-95.
15. 5-30xyätio-cholensäure. Helv Chim Acta 1937; 20: 1164-79.
16. THORN GW, EISENBERG H: Studies on desoxy-corticosterone. A synthetic adrenal cortical hormone. Endocrinology, 1939; 25: 39-46.
17. THORN GW, KOEPF GF, LEWIS RA et al.: Carbohydrate metabolism in Addison's disease. J Clin Invest 1940; 19: 813-32.
18. JAMES WE, LITTLE RC, SHUMWAY NP: Effect of desoxycorticosterone and ascorbic acid on rheumatoid arthritis. Am J Med Sci 1950;220:490-95.
19. KENDALL EC: Cortisone. Ann Intern Med 1950; 33: 787-96.
20. SPRAGUE RG, GASTINEAU CF, MASON HL et al.: Effect of synthetic 11-dehydrocorticosterone (compound A) in a subject with Addison's disease. Am J Med 1948; 4: 175-85.
21. POLLEY HF, MASON HL: Rheumatoid arthritis. Effects of certain steroids other than cortisone and of some adrenal cortex extracts. JAMA 1950; 193: 1474-81.
22. KENDALL EC: The development of cortisone as a therapeutic agent. Antibio & Chemother 1951; 1:7-15.
23. POLLEY HF, SLOCUMB CH: Behind the scenes with cortisone and ACTH. Mayo Clin Proc 1976;51:471-77.
24. HENCH PS, KENDALL EC, SLOCUMB CH et al.: The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: Compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Preliminary report. Proc Staff Mayo Clin 1949; 24: 181-97.
25. BENEDEK TG: Philip S. Hench, 1950. Op. cit. 4, 231-37.
26. MATTESON EL, HUNDER GG: Patient expectations in the clinical investigation of the first use of cortisone in rheumatoid arthritis: historical vignette. Int J Clin Rheumatol 2010; 5:419-24.
27. SPRAGUE RG, POWER MH, MASON HL et al.: Observations on the physiologic effects of cortisone and ACTH. Arch Intern Med 1950; 85: 199-258.
28. HENCH PS, KENDALL EC, SLOCUMB CH et al.: Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, Rheumatic fever and certain other conditions. Arch Intern Med 1950; 85: 545-666.
29. BUNIM JJ, KUTTNER AG, BALDWIN JS et al.: Cortisone and corticotropin in rheumatic fever and juvenile rheumatoid arthritis. JAMA 1952; 150: 1273-8.
30. MARKS HM: Cortisone, 1949: A year in the political life of a drug. Bull Hist Med 1992; 66: 419-39.
31. WARNER ME: Witness to a miracle: The initial cortisone trial: An interview with Richard Freyberg, M.D. Mayo Clin Proc 2001; 76: 529-32. (Pubitemid 32423136)
32. HENCH PS: The reversibility of certain rheumatic and nonrheumatic conditions by the use of cortisone or of the pituitary adrenocorticotropic hormone. Ann Intern Med 1952; 36: 1-38.
33. FREYBERG RH, TRAEGER CT, ADAMS CH et al.: Effectiveness of cortisone administered orally. Science 1950; 112:429.
34. CONN JW. LOUIS LH, FAJANS SS: The probability that compound F (17-hydroxycorticosterone) is the hormone produced by the normal human adrenal cortex. Science 1951; 113:713-4.
35. SALTER WT: A Textbook of Pharmacology. Philadelphia, WB Saunders Co., 1952, p. 552.
36. ANONYMOUS: Let the microbes do it. Cortisone synthesis made simple. Medicine on the Midway (University of Chicago Magazine), Autumn 1987: 21-4.
37. CALLOW RK: Expedition to Nigeria. MRC search for tropical plants. Br Med J 1950; 1: 1484-5.
38. MONACHINO J: Strophanthus, sarmentogenin, and cortisone. J NY Botanical Garden 1950;51:25-39.
39. LI CH, EVANS HM, SIMPSON ME: Adrenocortcotropin hormone. J Biol Chem 1943; 149:413-24.
40. SAYERS G, WHITE A, LONG CN: Preparation and properties of pituitary adrenocorticotropic hormone. J Biol Chem 1943; 149: 426-35.
41. HOFMANN K: Chemistry and function of polypeptide hormones. Ann Rev Biochem 1962;31:213-46.
42. th ed New York, Macmillan Publishing Co., 1980, pp. 1466-68.
43. BUNIM JJ, PECHES MM, BOLLET AJ: Studies on metacortandrolone and metacortandracin in rheumatoid arthritis. JAMA 1955; 157: 311-18.
44. COHEN A, TURNER RF, KANENSON WL et al.: Prolonged treatment of rheumatoid arthritis with prednisone (Meticorten). JAMA 1957; 165: 225-8.
45. FREYBERG RH, BERNTSEN CA JR, HELLMAN L: Further experiences with delta 1,9 alpha fluoro, 16 alpha hydroxyhydrocortisone (triamcinolone) in treatment of patients with rheumatoid arthritis. Arthritis Rheum 1958; 1:215-29.
46. BUNIM JJ, BLACK RL, LUTWAK L et al.: Studies on dexamethasone, a new synthetic steroid, in rheumatoid arthritis - a preliminary report. Arthritis Rheum 1958; 1: 313-31.
47. BOLAND EW: The treatment of rheumatoid arthritis with adrenocorticosteroids and their synthetic analogues: an appraisal of certain developments of the past decade. Ann NY Acad Sci 1959; 82: 887-901.
48. INGLE DJ: The biologic properties of cortisone: A review. J Clin Endoc 1950; 10: 1312-54.
49. O'DONNELL WM, FAJANS SS, WEINBAUM JG: Human adrenal cortex after administration of ACTH and cortisone; morphologic changes, Arch Intern Med 1951; 88: 28-35.
50. GOOD TA, BENTON JW, KELLEY VC: Symptomatology resulting from withdrawal of steroid hormone therapy. Arthritis Rheum 1959;2:299-321.
51. CALKINS E, ENGEL LL, MITCHELL DM et al.: Clinical, metabolic and endocrinologic effects of abrupt cessation of maintenance cortisone acetate therapy in rheumatoid arthritis. Arthritis Rheum 1960; 3: 204-17.
52. MEAKIN JW, TANTOGCO MS, CRABBÉ J et al.: Pituitary-adrenal function following long-term steroid therapy. Am J Med 1960; 29: 459-64.
53. POLLEY HF: Present therapeutic status of cortisone and its derivatives, with special reference to rheumatic diseases. Br Med J 1956; 2: 1253-9.
54. th ed. Philadelphia, Lea & Febiger, 1960, Chapter 22, p. 367.
55. BACON PA, BEARDWELL CG, MVLES AB et al.: Corticosteroid withdrawal in rheumatoid arthritis. Lancet 1966; 2: 935-7.
56. THORN GW: Clinical considerations in the use of corticosteroids. N Eng J Med 1966; 274:775-81.
57. HOLLANDER JL, BROWN EM, JESSAR RA et al.: Hydrocortisone and cortisone injected into arthritic joints. JAMA 1951; 147: 1629-35.
58. HOLLANDER JL: Intra-articular hydrocortisone in the treatment of arthritis. Ann Intern Med 1953; 39: 735-46.
59. AUSTEN FK, CALKINS E: Serial studies of synovial fluid in evaluating intra-articular agents. Ann Rheum Dis 1955; 14: 283-87.
60. BUNIM: op. cit. 55. 362.
61. RAGAN C: Corticotropin, cortisone and related steroids in clinical medicine: practical considerations. Bull NY Acad Med 1953; 29: 355-76.
62. FREYBERG RH, TRAEGER CH, PATTERSON M et al.: Problems of prolonged cortisone treatment for rheumatoid arthritis. JAMA 1951; 147: 1538-43.
63. CLARKE WS, TONNING HO, KULKA JP et al.: Observations on the use of cortisone and ACTH in rheumatoid arthritis. New Eng J Med 1953; 249: 635-42.
64. HOWELL DS, RAGAN C: The course of rheumatoid arthritis during four years of induced hyperadrenalism (IHA). Medicine 1956; 35: 83-118.
65. GOOLKER P, SCHEIN J: Psychic effects of ACTH and cortisone. Psychosom Med 1953; 15:589-612.
66. ROTSTEIN J, GOOD RA: Steroid pseudorheumatism. Arch Intern Med 1957; 99: 545-55.
67. SLOCUMB CH: Rheumatic complaints during chronic hypercortisonism and syndromes during withdrawal of cortisone in rheumatic patients. Proc Staff Mayo Clin 1953; 28: 655-7.
68. FREIBERGER RH, KAMMERER WH, RIVELIS AL: Peptic ulcer in rheumatoid patients receiving corticosteroid therapy. Radiology 1958;71:542-7.
69. CURTISS PH, CLARK WS, HERNDON CH: Vertebral fracture resulting from prolonged cortisone and corticotropin therapy. JAMA 1954; 156:467-9.
70. ZIZIC TM, MARCOUX C, HUNGERFORD DS et al.: The early diagnosis of ischemic necrosis of bone. Arthritis Rheum 1986; 1177-86. (Pubitemid 16005507)
71. BLACK RL, OGLESBY RB, VON SALLMANN L et al.: Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis. JAMA 1960; 174: 166-71.
72. LUKERT BP, RAISZ LG: Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann Intern Med 1990; 112: 352-62.
73. HEIMANN WG, FREIBERGER RH: Avascular necrosis of the femoral and humeral heads after high-dosage corticosteroid therapy. N Eng J Med 1960; 263: 672-5.
74. SUTTON RD, BENEDEK TG, EDWARDS GA: Aseptic bone necrosis and corticosteroid therapy. Arch Intern Med 1963; 112: 594-602.
75. BUNIM: op. cit. 55. 361-2.
76. th ed. Philadelphia, Lea & Febiger, 1972, Chapter 31, pp. 495-6.
77. nd ed. Philadelphia, JB Lippincott, 1988, Chapter 30, p. 385.
78. BRODIE BB, LOWMAN EW, BURNS JJ et al.: Observations on the antirheumatic and physiologic effects of phenylbutazone (Butazolidin) and some comparisons with cortisone. Am J Med 1954; 16: 181-90.
79. SMYTH CJ: Indomethacin in rheumatoid arthritis. A comparative objective evaluation with adrenocorticosteroids. Arthritis Rheum 1965;8:921-42.
80. KANTOR TG: Ibuprofen. Ann Intern Med 1979;91:877-82. (Pubitemid 10182666)
81. HILL HF, HILL AG, ANSELL BM et al.: Naproxen. A new non-hormonal anti-inflammatory agent. Ann Rheum Dis 1974; 33: 12-9.
82. LEWIS JR: New antirheumatic agents. Fenoprofen calcium (Nalfon), Naproxen (Naprosyn), and Tolmetin sodium (Tolectin.) JAMA 1977; 237: 1260-61. (Pubitemid 8064282)
83. BENEDEK TG: Methotrexate: from its introduction to non-oncologic therapeutics to anti-TNF-α. Clin Exp Rheumatol 2010; 28: S3-8.
84. VAN EVERDINGEN AA, JACOBS JW, SIEWERTSZ VAN REESEMMA DR, BIJLSMA JW: Low-dose prednisone therapy for patients with early active Rheumatoid Arthritis: Clinical efficacy, disease-modifying properties, and side effects. A randomized, doubleblind, placebo-controlled clinical trial. Ann Intern Med 2002; 136: 1-12. (Pubitemid 34038692)